Posted on August 29, 2020 by Sitemaster
The Prostate Active Surveillance Study (PASS), initially funded by the Canary Foundation, is a multi-center research study for men with low-risk disease who have chosen active surveillance (AS) to manage their prostate cancer. Active surveillance in PASS means closely monitoring men with prostate cancer and offering treatment if test results show the cancer is getting worse. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: active, AS, calculator, PASS, progression, risk, surveillance | Leave a comment »
Posted on July 15, 2011 by Sitemaster
A new paper in the Journal of Clinical Oncology provides some interesting insights into the relative merits of the two major prostate cancer risk calculators widely used today in North America: the original PCPT-based risk calculator (PRC) and the Sunnybrook risk calculator (SRC). … READ MORE …
Filed under: Diagnosis, Risk | Tagged: biopsy, calculator, prognosis, Prostate Cancer Prevention Trial, risk, Sunnybrook | Leave a comment »
Posted on May 13, 2011 by Sitemaster
A newly published study has suggested that the risk calculator based on data from the European Randomized Study of Screening for Prostate Cancer (ERSPC-RC) may be a better predictor of risk for prostate cancer in Canadians that the risk calculator based on the US-based Prostate Cancer Prevention Trial (PCPT-RC). … READ MORE …
Filed under: Diagnosis, Risk | Tagged: calculator, ERSPC, PCPT, risk | Leave a comment »
Posted on March 13, 2011 by Sitemaster
The PCPT prostate cancer risk calculator is a widely used tool designed to help men and their doctors assess whether they should have a prostate biopsy based on the patient’s age, PSA level, and supplementary data. The calculator asks about family history of prostate cancer in one simple question requiring only a Yes/No answer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: calculator, family history, risk, specificity | Leave a comment »
Posted on July 21, 2010 by Sitemaster
PSA doubling time or PSADT is a valuable prognostic factor in assessing the need for second- or even third-line treatment in men with biochemical progression of prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: calculator, on-line, PSA doubling time, PSADT | 5 Comments »
Posted on April 7, 2010 by Sitemaster
Long, long ago (in September 2008), we initially reported on the existence of a prostate cancer decision support tool (then in very early-stage development) known as the CaP Calculator. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: calculator, CaP Calculator, decision, support, tool | Leave a comment »
Posted on September 4, 2008 by Sitemaster
van den Bergh et al. have conducted a careful investigation of the potential problem caused by the use of different predictive tools for risk of a positive result of prostate biopsy. It is very clear that different nomograms and similar tools can produce divergent outcomes in the same man. … READ MORE …
Filed under: Diagnosis | Tagged: calculator, cancer, nomogram, prostate, risk | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 